KC enters the week with a rare combination: a fresh Morgan Stanley initiation on the bull side and a borrow market that has been running near capacity for over a month.
The most significant development this week is the analyst action. Morgan Stanley initiated coverage on July 7 with an Overweight rating and a $15 price target — a meaningful endorsement for a stock trading at $9.44. That target represents roughly 59% upside from current levels, and it aligns with the broader Street direction. Jefferies has held a Buy with a $19 target since March, and Deutsche Bank initiated at Buy last September with a $21 target. The consensus is firmly constructive, with all three active coverage firms rating the stock positively. The contrarian voice on the panel is Bank of America, which held Neutral with a $3.20 target as of August 2024 — but that is stale and almost certainly no longer reflects the stock's 3x move since then.
The borrow picture tells a story of persistent and unusual tightness. Availability has been near zero for weeks — it dropped to just 0.03% in early June and spent several days in late June below 1%. Tuesday's reading was 3.6%, briefly touching the floor of the lending pool again before recovering slightly to 7.7% by Tuesday close. Cost to borrow has been running at 13–16% for most of the past six weeks, near the top of its recent range, reflecting that demand for borrows continues to outstrip supply. Short interest itself is modest at 2.4% of free float and drifted slightly lower this week, so this is not a crowded short — it is a stock where even a small number of shorts are competing for very scarce borrow. The ORTEX short score of 66.6 has been gradually declining from its 67.4 peak last week, a softening that mirrors the slight reduction in short shares outstanding.
Options positioning has shifted more cautious relative to the stock's own recent history, though it remains far from extreme. The put/call ratio is running at 0.54, above its 20-day average of 0.45 — a roughly three-quarter standard deviation move toward more defensive positioning. The 52-week range for the PCR runs from 0.15 to 0.77, putting the current reading in the middle of that range. Notably, the PCR jumped sharply in late June from the 0.30 zone it had occupied for most of May and early June, suggesting options traders shifted their hedging stance following the stock's sharp one-month decline of 19%.
The earnings calendar adds a near-term reference point. KC reports next on August 21. The last two print cycles were uninspiring — the May 2026 quarter produced a 1-day decline of 3.1% and a 5-day loss of 2.2%, while the prior print fell 7.7% on the day. The pattern points to a stock where quarterly events have been selling opportunities rather than catalysts, even as the fundamental narrative improves. The institutional base is concentrated: Kingsoft Corporation holds 33% and Xiaomi holds 10%, leaving relatively thin free float in the hands of active managers. Artisan Partners trimmed its position by 1.67 million shares in Q1, while UBS Asset Management and Citigroup both added. The ownership picture is not alarming but it does mean that thin availability in the borrow market can persist even with modest short interest.
The setup heading into August is therefore one where the Street has just grown more vocal on the upside case, but the stock is 19% below its one-month high and borrow conditions remain structurally tight — a combination that makes the August 21 print a sharper-than-usual binary for how positioning resolves.
See the live data behind this article on ORTEX.
Open KC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
